Gerdau Q3: Valuation Appeal vs. One-Engine Reality

What happened

A Seeking Alpha article reiterates Gerdau as a Buy, citing a low EV/EBITDA of 4.2x versus a sector average of 7.8x, along with robust North American operations and diversified geography. Meanwhile, the DeepValue master report from earlier in 2026 rated the stock WAIT, noting that North America generates the bulk of EBITDA with a 24.1% margin in 1Q26, while Brazil remains weak with import penetration above 22% and margin near 9%. The article's optimism rests on competitive advantages and valuation but does not address the risk of North American backlog decline or Brazil trade remedies failing to materialize. As of the article's October 2026 date, the stock has likely risen further, narrowing the margin of safety relative to the master report's attractive entry level of $4.40. The Q3 results presumably reinforced North American strength but likely did not resolve Brazil's structural challenges.

Implication

The valuation gap (4.2x EV/EBITDA) is attractive if Brazil trade remedies materialize and North America backlog holds above 90 days, but the master report's base case values the stock at $5.20 with only a 45% probability, while the bear case of $4.10 carries a 30% probability. Given the article's lack of new fundamental data and its failure to address Brazil import pressure and free cash flow concerns, existing holders should maintain a WAIT stance and new buyers should wait for a pullback toward $4.40 or evidence of Brazil margin improvement above 10%. The article's claim of 'healthy cash generation' conflicts with the master report's 1Q26 free cash flow of only R$16M and R$4.7B capex, so investors should confirm Q3 cash conversion before adding. A break above the master report's trim level of $5.80 on sustained operational improvement would warrant a reassessment, but current evidence does not support chasing the stock.

Thesis delta

The new article does not materially change the investment thesis; it reiterates the buy case based on valuation multiples but ignores the master report's concerns about Brazil import pressure and the need for trade remedies. The master report's WAIT rating remains appropriate until there is clearer evidence of Brazil margin recovery or North America backlog durability beyond current levels.